A 12-month comparison of brief psychodynamic psychotherapy and pharmacotherapy treatment in subjects with generalised anxiety disorders in a community setting

European Psychiatry

Volumn 22, Issue 8, 2007, Pages 530-539

  Ferrero, Andrea ^a,b   Pierò, Andrea ^a,c   Fassina, Simona ^a,b   Massola, Tiziana ^a   Lanteri, Antonello ^a   Daga, Giovanni Abbate ^c   Fassino, Secondo ^c  

^a ASL 7 of Chivasso   (Italy)

^b SAIGA Institute of Research   (Italy)

^c UNIVERSITY OF TURIN   (Italy)

Author keywords

Agoraphobia; Anxiety disorders; Brief psychotherapy; Drug; Follow up; Medication; Mental health; Outcome; Panic; Personality disorders; Treatment

Indexed keywords

BENZODIAZEPINE; CITALOPRAM; ESCITALOPRAM; MIRTAZAPINE; PAROXETINE; SERTRALINE; VENLAFAXINE;

ADULT; ARTICLE; CLINICAL GLOBAL IMPRESSION SCALE; CONTROLLED STUDY; FEMALE; FOLLOW UP; GENERALIZED ANXIETY DISORDER; HAMILTON SCALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PATIENT SATISFACTION; PERSONALITY DISORDER; PRIORITY JOURNAL; RATING SCALE; REMISSION; SCORING SYSTEM; TREATMENT OUTCOME;

ADOLESCENT; ADULT; ANTI-ANXIETY AGENTS; ANXIETY DISORDERS; COMBINED MODALITY THERAPY; COMMUNITY MENTAL HEALTH SERVICES; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; PATIENT SATISFACTION; PERSONALITY ASSESSMENT; PSYCHOANALYTIC THERAPY; PSYCHOTHERAPY, BRIEF; SEROTONIN UPTAKE INHIBITORS;

EID: 36148942846     PISSN: 09249338     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.eurpsy.2007.07.004     Document Type: Article

References (55)

1. Addis M.E., Hatgis C., Cardemil E., Jacob K., Krasnow A.D., and Mansfield A. Effectiveness of cognitive-behavioral treatment for panic disorder versus treatment as usual in a managed care setting. J Consult Clin Psychol 72 (2004) 625-635
2. American Psychiatric Association. Practice guidelines for the treatment of patients with panic disorder. Am J Psychiatry 155 5 (1998) 1-34
3. American Psychiatric Association. DSM-IV: diagnostic and statistical manual of mental disorders. 4th ed. (2000), American Psychiatric Association, Washington, DC
4. American Psychiatric Association. Guideline watch: practice guideline for the treatment of patients with panic disorder (2006), Oxford University Press, New York
5. Bacaltchuk J., Hay P., and Trefiglio R. Antidepressants versus psychological treatments and their combination for bulimia nervosa. Cochrane Database Syst Rev 4 (2001) CD003385
6. Baldwin D.S., Anderson I.M., Nutt D.J., Bandelow B., Bond A., and Davidson J.R. British Association for Psychopharmacology. Evidence-based guidelines for the pharmacological treatment of anxiety disorders: recommendations from the British Association for Psychopharmacology. J Psychopharmacol 19 6 (2005) 567-596
7. Ballenger J.C. Clinical guidelines for establishing remission in patients with depression and anxiety. J Clin Psychiatry 60 22 (1999) 29-34
8. Balon R. Developments in treatment of anxiety disorders: psychotherapy, pharmacotherapy, and psychosurgery. Depress Anxiety 19 2 (2004) 63-76
9. Bandelow B., Zohar J., Hollander E., Kasper S., and Moller H.J. World Federation of Societies of Biological Psychiatry Task Force on Treatment Guidelines for Anxiety, Obsessive-Compulsive and Posttraumatic Stress Disorders. World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the pharmacological treatment of anxiety, obsessive-compulsive and posttraumatic stress disorders. World J Biol Psychiatry 3 4 (2002) 171-199
10. Black D.W. Efficacy of combined pharmacotherapy and psychotherapy versus monotherapy in the treatment of anxiety disorders. CNS Spectr 11 (2006) 29-33
11. Connor K.M., Davidson J.R., Chung H., Yang R., and Clary C.M. Multidimensional effects of sertraline in social anxiety disorder. Depress Anxiety 23 1 (2006) 6-10
12. Craske M.G., Golinelli D., Stein M.B., Roy-Byrne P., Bystritsky A., and Sherbourne C. Does the addition of cognitive behavioral therapy improve panic disorder treatment outcome relative to medication alone in the primary-care setting?. Psychol Med 35 11 (2005) 1645-1654
13. Davidson J.R., Foa E.B., Huppert J.D., Keefe F.J., Franklin M.E., Compton J.S., et al. Fluoxetine, comprehensive cognitive behavioral therapy, and placebo in generalized social phobia. Arch Gen Psychiatry 61 (2004) 1005-1013
14. Dewan M.J., Steenbarger B.N., and Greenberg R.P. Art and science of brief psychotherapies (2004), American Psychiatric Press, Washington, DC
15. Fassino S., Abbate-Daga G., Delsedime N., Busso F., Pierò A., and Rovera G.G. Baseline personality characteristics of responders to 6-month psychotherapy in eating disorders: preliminary data. Eat Weight Disord 10 1 (2005) 40-50
16. Fassino S., Abbate-Daga G., Pierò A., Leombruni P., and Rovera G.G. Dropout from brief psychotherapy within a combination treatment in bulimia nervosa: role of personality and anger. Psychother Psychosom 72 (2003) 203-210
17. Fassino S., Abbate-Daga G., Pierò A., and Rovera G.G. Dropout from brief psychotherapy in anorexia nervosa. Psychother Psychosom 71 (2002) 200-206
18. Fassino S., Ferrero A., Pierò A., Mongelli E., Caviglia M.L., Delsedime N., et al. Rehabilitative residential treatment in patients with severe mental disorders: factors associated with short term outcome. Am J Orthopsychiatry 74 (2004) 33-42
19. Fassino S., Pierò A., Mongelli E., Caviglia M.L., Delsedime N., Busso F., et al. Baseline personality functioning correlates with 6 month outcome in schizophrenia. Eur Psychiatry 18 (2003) 93-100
20. Fava G.A., Ruini C., Rafanelli C., Finos L., Salmaso L., Mangelli L., et al. Well-being therapy of generalized anxiety disorder. Psychother Psychosom 74 1 (2005) 26-30
21. First M.B., Gibbon M., Spitzer R.L., Williams J.B.W., and Benjamin L.S. SCID II personality questionnaire (1997), American Psychiatric Press, Washington, DC
22. First M.B., Spitzer R.L., Gibbon M., and Williams J.B.W. Structured Clinical Interview for DSM-IV Axis I Disorders: outpatient edition (SCID-O/P, version 2.0) (1996), Biometric Research, New York State Psychiatric Institute, New York
23. Gabbard G.O., and Freedman R. Psychotherapy in the journal: what's missing?. Am J Psychiatry 163 2 (2006) 182-184
24. Hamilton M. The assessment of anxiety states by rating. Br J Med Psychol 32 (1959) 50-55
25. Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry 23 (1960) 56
26. Hilsenroth M.J., Ackerman S.J., and Blagys M.D. Reliability and validity of DSM IV Axis V. Am J Psychiatry 157 (2000) 1858-1863
27. Hilsenroth M.J., Peters E.J., and Ackerman S.J. The development of therapeutic alliance during psychological assessment: patient and therapist perspectives across treatment. J Pers Assess 83 (2004) 332-344
28. Hollifield M., Thompson P.M., Ruiz J.E., and Uhlenhuth E.H. Potential effectiveness and safety of olanzapine in refractory panic disorder. Depress Anxiety 21 1 (2005) 33-40
29. Hunot V., Churchill R., Teixeira V., and Silva de Lima M. Psychological therapies for generalized anxiety disorder. Cochrane Database Syst Rev 1 (2007) CD001848
30. Issakidis C., and Andrews G. Pretreatment attrition and dropout in an outpatient clinic for anxiety disorders. Acta Psychiatr Scand 109 6 (2004) 426-433
31. Kessing L.V., Hansen H.V., Ruggeri M., and Bech P. Satisfaction with treatment among patients with depressive and bipolar disorders. Soc Psychiatry Psychiatr Epidemiol 41 2 (2006) 148-155
32. Lee H.J., Lee M.S., Kang R.H., Kim H., Kim S.D., Kee B.S., et al. Influence of the serotonin transporter promoter gene polymorphism on susceptibility to posttraumatic stress disorder. Depress Anxiety 21 3 (2005) 135-139
33. Leichsenring F. Are psychodynamic and psychoanalytic therapies effective? A review of empirical data. Int J Psychoanal 86 3 (2005) 841-868
34. Leichsenring F., Rabung S., and Leibing E. The efficacy of short-term psychodynamic psychotherapy in specific psychiatric disorders: a meta-analysis. Arch Gen Psychiatry 61 12 (2004) 1208-1216
35. Leichsenring F., and Ruger U. Psychotherapy and evidence-based medicine (EBM)-randomized controlled vs. naturalistic studies: is there only one gold standard?. Z Psychosom Med Psychother 50 2 (2004) 203-217
36. Linden M., Zubraegel D., Baer T., Franke U., and Schlattmann P. Efficacy of cognitive behaviour therapy in generalized anxiety disorders: results of a controlled clinical trial (Berlin CBT-GAD Study). Psychother Psychosom 74 (2005) 36-42
37. Marciniak M.D., Lage M.J., Dunayevich E., Russell J.M., Bowman L., Landbloom R.P., et al. The cost of treating anxiety: the medical and demographic correlates that impact total medical costs. Depress Anxiety 21 4 (2005) 178-184
38. Milrod B., Busch F., Leon A.C., Aronson A., Roiphe J., Rudden M., et al. A pilot open trial of brief psychodynamic psychotherapy for panic disorder. J Psychother Pract Res 10 4 (2001) 239-245
39. Milrod B., Busch F., Leon A.C., Shapiro T., Aronson A., Roiphe J., et al. Open trial of psychodynamic psychotherapy for panic disorder: a pilot study. Am J Psychiatry 157 11 (2000) 1878-1880
40. Mitte K. Meta-analysis of cognitive-behavioral treatments for generalized anxiety disorder: a comparison with pharmacotherapy. Psychol Bull 131 5 (2005) 785-795
41. Mosak H. Adlerian psychotherapy. In: Corsini R., and Wedding D. (Eds). Current psychotherapies (1989), Peacock, Itasca, IL 65-118
42. Prasko J., Houbova P., Novak T., Zalesky R., Espa-Cervena K., Paskova B., et al. Influence of personality disorder on the treatment of panic disorder: comparison study. Neuroendocrinol Lett 26 6 (2005) 667-674
43. Roy-Byrne P.P., Craske M.G., Stein M.B., Sullivan G., Bystritsky A., Katon W., et al. A randomized effectiveness trial of cognitive-behavioral therapy and medication for primary care panic disorder. Arch Gen Psychiatry 62 (2005) 290-298
44. Roy-Byrne P., Russo J., Pollack M., Stewart R., Bystrisky A., Bell J., et al. Personality and symptom sensitivity predictors of alprazolam withdrawal in panic disorder. Psychol Med 33 3 (2003) 511-518
45. Rubio G., and Lopez-Ibor Jr. J.J. What can be learnt from the natural history of anxiety disorders?. Eur Psychiatry 22 2 (2007) 80-86
46. Ruggeri M., Salvi G., Perwanger V., Phelan M., Pellegrini N., and Parabiaghi A. Satisfaction with community and hospital-based emergency services amongst severely mentally ill service users: a comparison study in south Verona and south London. Soc Psychiatry Psychiatr Epidemiol 41 4 (2006) 302-309
47. Sihvo S., Hämäläinen J., Kiviruusu O., Pirkola S., and Isometsä E. Treatment of anxiety disorders in the Finnish general population. J Affect Dis 96 1-2 (2006) 31-38
48. SPSS Base 11.0. Application guide (2000), SPSS, Chicago, IL
49. Starcevic V. Anxiety states: a review of conceptual and treatment issues. Curr Opin Psychiatry 19 (2006) 79-83
50. Stein D.J., Kasper S., Andersen E.W., Nil R., and Lader M. Escitalopram in the treatment of social anxiety disorder: analysis of efficacy for different clinical subgroups and symptom dimensions. Depress Anxiety 20 4 (2004) 175-181
51. Svartberg M., Stiles T.C., and Seltzer M.H. Randomized, controlled trial of the effectiveness of short-term dynamic psychotherapy and cognitive therapy for cluster C personality disorders. Am J Psychiatry 161 5 (2004) 810-817
52. Tenbrink D. Zur Theorie und Praxis der Psychodinamischen Kerzpsychoterapie. Z Individual Psychol 1 (1997) 3-31 (in German)
53. Vinnars B., Barber J.P., Noren K., Gallop R., and Weinryb R.M. Manualized supportive-expressive psychotherapy versus nonmanualized community-delivered psychodynamic therapy for patients with personality disorders: bridging efficacy and effectiveness. Am J Psychiatry 162 10 (2005) 1933-1940
54. Westen D., Novotny C.M., and Thompson-Brenner H. The empirical status of empirically supported psychotherapies: assumptions, findings, and reporting in controlled clinical trials. Psychol Bull 130 4 (2004) 631-633
55. Wittchen H.U. Generalized anxiety disorder: prevalence, burden, and cost to society. Depress Anxiety 16 4 (2002) 162-171